GFAP and depressive symptom measurement: However, longitudinal analyses performed with the community-based cohort showed that the combination of SCC with APOE ε4 and GFAP could have the potential to contribute to the differentiation between future risk of all-cause dementia and risk of depression in the absence of dementia.